Ernst E, Pittler M H
Department of Complementary Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, 25 Victoria Park Road, Exeter EX2 4NT, U.K.
Wien Med Wochenschr. 2002;152(7-8):183-9. doi: 10.1046/j.1563-258x.2002.01112.x.
Health risks associated with the use of herbal medicinal products (HMPs) are often an emotionally discussed issue. The topic is, however, important not least because of the present popularity of HMPs. This article aims to provide a factual overview of this complex subject. The evidence relating to the toxicity, interactions and quality of a number of HMPs is reviewed. Toxicity data indicate that some HMPs have the potential to cause serious adverse events and fatalities. HMPs affect pharmacokinetic and pharmacodynamic factors and thus cause herb-drug interactions. Reports of HMPs affected by contamination, adulteration or substitution of botanical material have repeatedly caused concern. Asian HMPs are most often implicated. It is concluded that HMPs are not free of risk. More research and more information are required in order to maximize consumers' safety.
与使用草药产品(HMPs)相关的健康风险常常是一个引发激烈讨论的话题。然而,这个话题很重要,尤其是考虑到目前HMPs的受欢迎程度。本文旨在对这个复杂的主题提供一个基于事实的概述。对一些HMPs的毒性、相互作用和质量相关的证据进行了综述。毒性数据表明,一些HMPs有可能导致严重的不良事件和死亡。HMPs会影响药代动力学和药效学因素,从而引发草药与药物的相互作用。关于HMPs受到植物材料污染、掺假或替代影响的报告屡屡引发关注。亚洲的HMPs最常受到牵连。得出的结论是,HMPs并非没有风险。为了最大限度地保障消费者安全,需要更多的研究和更多的信息。